Solving Patient Matching in Rare Disease Trials
Apr 29, 2026 - 00:33:36
Radio and PodcastLive Radio & Podcasts
Science & Medicine
The JCA is live
After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member state...
Related Episodes
Continue listening to more episodes from Rare Disease, Cell & Gene Therapy Monthly RoundUp.
Rare Disease Day Special: The stats and stories you need to hear.
Feb 27, 2026 - 00:32:20
2026 Trends: A Year Of Change & Opportunity
Jan 30, 2026 - 00:17:08
Going To Glasgow: ISPOR 2025
Dec 2, 2025 - 00:22:15
Conversations Beyond the Clinic
Nov 3, 2025 - 00:26:18
Voices Uncovered: Understanding Mental Health in Rare Diseases using Social Listening
Sep 29, 2025 - 00:30:05
OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years
Jul 1, 2025 - 00:27:44